Elmind Capital, LP

In its 13F for Q2 2026 (holdings as of June 30, 2026, filed August 14, 2026), Elmind Capital, LP reported 35 stock positions worth $398.0 million. Its top holding was Cogent Biosciences (COGT) at 11.4% of the portfolio, followed by Syndax Pharmaceuticals (SNDX, 10.2%) and Celldex Therapeutics (CLDX, 9.3%). Compared with Q1 2026, it opened 5 new positions, sold out of 4, added to 9 and reduced 6. The biggest buy was Relay Therapeutics (RLAY, shares +173%) and the biggest sale an exit from Kalvista Pharmaceuticals (KALV).

Most Recent 13F
Q2 2026
Location
NEW YORK, NY
CIK
0002052213
Portfolio Value
$398.0M (Q2 2026)
SEC Filing
0001013594-26-000910 ↗ filed Aug 14, 2026

Holdings Value

0$100.0M$200.0M$300.0M$400.0M Q4 2025: $338.9M Q4 2025 Q1 2026: $352.2M Q1 2026 Q2 2026: $398.0M $398.0M Q2 2026

Holdings 35 stocks · $398.0M

COGT Cogent Biosciences Inc. 11.38% 1,170,740 $45.3M No change
SNDX Syndax Pharmaceuticals Inc. 10.19% 1,855,000 $40.6M No change
CLDX Celldex Therapeutics Inc. 9.25% 990,000 $36.8M Add +14.4%
RLAY Relay Therapeutics Inc. 6.89% 1,465,279 $27.4M Add +172.9%
PCVX Vaxcyte Inc. 6.61% 452,340 $26.3M Add +42.9%
VERA Vera Therapeutics Inc. 4.71% 436,518 $18.7M Reduce -9.5%
PHVS Pharvaris NV 4.57% 525,750 $18.2M Add +10.5%
VRDN Viridian Therapeutics Inc. 4.55% 984,931 $18.1M Add +84.1%
CTMX Cytomx Therapeutics Inc. 4.29% 4,550,000 $17.1M No change
TVTX Travere Therapeutics Inc. 4.18% 292,600 $16.6M Add +64.8%
LEGN Legend Biotech Corp.-ADR 4.14% 570,569 $16.5M New
BEAM Beam Therapeutics Inc. 4.11% 476,338 $16.3M No change
CGEM Cullinan Therapeutics Inc. 3.16% 690,000 $12.6M Add +30.2%
NRIX Nurix Therapeutics Inc. 2.80% 460,000 $11.2M No change
KRYS Krystal Biotech Inc. 2.05% 22,000 $8.2M No change
UTHR United Therapeutics Corp. 2.04% 15,000 $8.1M No change
SMMT Summit Therapeutics Inc. 1.81% 493,820 $7.2M New
INSM Insmed Inc. 1.74% 65,000 $6.9M New
BCRX Biocryst Pharmaceuticals Inc. 1.31% 520,000 $5.2M Reduce -48.0%
MBX MBX Biosciences Inc. 1.26% 91,000 $5.0M Reduce -56.9%
PTGX Protagonist Therapeutics Inc. 1.17% 38,000 $4.7M No change
URGN Urogen Pharma Ltd. 1.11% 120,000 $4.4M Reduce -45.5%
DBVT DBV Technologies SA-Spon ADR 1.09% 265,000 $4.3M No change
ALMS Alumis Inc. 0.92% 130,000 $3.7M No change
SUPN Supernus Pharmaceuticals Inc. 0.82% 70,000 $3.3M Add +250.0%
BMRN Biomarin Pharmaceutical Inc. 0.68% 47,000 $2.7M No change
IMCR Immunocore Holdings PLC-ADR 0.65% 81,143 $2.6M Add +39.3%
AMLX Amylyx Pharmaceuticals Inc. 0.51% 112,000 $2.0M No change
ALEC Alector Inc. 0.45% 900,000 $1.8M No change
SEPN Septerna Inc. 0.42% 49,444 $1.7M New
DSGN Design Therapeutics Inc. 0.39% 107,900 $1.6M Reduce -48.1%
STRO Sutro Biopharma Inc. 0.27% 32,037 $1.1M New
WVE Wave Life Sciences Ltd. 0.26% 177,846 $1.0M No change
TYRA Tyra Biosciences Inc. 0.16% 20,000 $639K Reduce -94.3%
ENGN Engene Therapeutics Inc. 0.09% 210,000 $363K No change

Portfolio Sells Q1 2026 → Q2 2026

KALV Kalvista Pharmaceuticals Inc. Sold out 0.00% −5.84
CGON CG Oncology Inc. Sold out 0.00% −5.61
TYRA Tyra Biosciences Inc. Reduce -94.3% 0.16% −3.65
BCRX Biocryst Pharmaceuticals Inc. Reduce -48.0% 1.31% −1.40
VERA Vera Therapeutics Inc. Reduce -9.5% 4.71% −0.81
APLS Apellis Pharmaceuticals Inc. Sold out 0.00% −0.57
MBX MBX Biosciences Inc. Reduce -56.9% 1.26% −0.53
DSGN Design Therapeutics Inc. Reduce -48.1% 0.39% −0.24
EWTX Edgewise Therapeutics Inc. Sold out 0.00% −0.09
URGN Urogen Pharma Ltd. Reduce -45.5% 1.11% −0.01

Portfolio Buys Q1 2026 → Q2 2026

RLAY Relay Therapeutics Inc. Add +172.9% 6.89% +5.37
LEGN Legend Biotech Corp.-ADR New 4.14% +4.14
TVTX Travere Therapeutics Inc. Add +64.8% 4.18% +2.68
SMMT Summit Therapeutics Inc. New 1.81% +1.81
INSM Insmed Inc. New 1.74% +1.74
VRDN Viridian Therapeutics Inc. Add +84.1% 4.55% +1.57
CLDX Celldex Therapeutics Inc. Add +14.4% 9.25% +1.47
PCVX Vaxcyte Inc. Add +42.9% 6.61% +1.38
CGEM Cullinan Therapeutics Inc. Add +30.2% 3.16% +1.02
PHVS Pharvaris NV Add +10.5% 4.57% +0.75
SUPN Supernus Pharmaceuticals Inc. Add +250.0% 0.82% +0.52
SEPN Septerna Inc. New 0.42% +0.42
STRO Sutro Biopharma Inc. New 0.27% +0.27
IMCR Immunocore Holdings PLC-ADR Add +39.3% 0.65% +0.15

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 35$398.0MCOGT, SNDX, CLDX, RLAY, PCVX
Q1 2026 34$352.2MCOGT, SNDX, CLDX, CTMX, KALV
Q4 2025 34$338.9MCOGT, SNDX, VRDN, VERA, CLDX